PeptiDream Inc. (TYO:4587)

Market Cap	195.95B -34.0%
Revenue (ttm)	17.93B -62.5%
Net Income	-5.82B
EPS	-45.01
Shares Out	129.21M
PE Ratio	n/a
Forward PE	13.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	870,900
Average Volume	639,365
Open	1,550.00
Previous Close	1,558.50
Day's Range	1,496.00 - 1,557.50
52-Week Range	1,440.00 - 2,389.00
Beta	0.07
RSI	36.81
Earnings Date	Feb 16, 2026

About PeptiDream

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform that enables the production of non-standard peptide libraries for the identification of potent and selective macrocyclic peptide candidates, which then can be developed into peptide-based, small molecule-based, peptide-drug conjugate, and multi-functional peptide conjugates...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 756
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4587

Financial Performance

In 2024, PeptiDream's revenue was 46.68 billion, an increase of 62.57% compared to the previous year's 28.71 billion. Earnings were 15.01 billion, an increase of 394.70%.